AVTX
Avalo Therapeutics Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||
| Capital Expenditures | — | — | — | 95,000 | 113,000 | 63,000 | 262,013 | 564,415 | 23,325 | 34,883 | 19,984 |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||
| Free Cash Flow | — | — | — | -26.8M | -71.0M | -40.6M | -19.4M | -3.7M | 12.6M | -14.6M | -10.2M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — |